Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
Clinical trial NCT05222984 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05222984
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-29
- Primary completion
- 2027-03-02
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.